RIPK3 and metabolic dysfunction-associated steatotic liver disease: Gautheron et al. (2014) have confirmed that RIP3-dependent necroptosis regulates NAFLD-induced liver fibrosis, and our research shows that increases in the levels of markers of necroptosis (RIP1, RIP3, and p-MLKL) can be induced by the NAFLD mouse model.